Frontlight ResearchEarly access
Trial site
Tian Jin Medicial University Cancer Institute&Hospital
- 2running trials
The trials here
What the 2 trials at this site are about, from their registry records.
- Conditions
- Triple-negative breast cancer2 trials
- Phase
- Phase 1/21 trial
- Phase 31 trial
- Status
- Active, not recruiting2 trials
- Lead sponsor
- Biotheus Inc.2 trials
Running trials
Active, not recruiting
Active, not recruiting
A Study of PM8002 Plus Nab-paclitaxel as First Line Therapy for TNBC
Site data: ClinicalTrials.govUpdated 12 Nov 2026